Drug Pricing Tussle Reaches The PMO
  • Gaurav Sarkar
  • Aug 06 2013

August 6: The tussle between drug companies, the regulator and the government over drug pricing policy has reached the Prime Minister's Office. Companies highlighted discrepancies between the policy document approved by the Cabinet and the final order. The PMO has written to the Department of Pharmaceuticals and the regulator the NPAA, seeking clarity. Bloomberg TV India brings you an update on the situation as it stands now.